Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Nulibry, fosdenopterin, Metal Metabolism, Inborn Errors, Date of authorisation: 15/09/2022, Revision: 2, Status: Authorised
TO: